|
Market Closed -
Hong Kong S.E.
04:08:07 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 21.22 HKD | +1.82% |
|
-7.09% | -30.38% |
| 08-27 | Medtide Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-31 | Medtide Names CFO | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Life Sciences Tools and Services | |||||
Medical Labs & Research | 282M | 351M | 337M | 442M | 570M |
Total Assets | 1.14B | 1.24B | 1.31B | 1.17B | 1.81B |
Interest Expense | -4.44M | -1.28M | -224K | -1.14M | -1.24M |
Income Tax Expense | 9.11M | 13.58M | 13.07M | 19.28M | 33.37M |
CAPEX | -40.13M | -92.15M | -55.18M | -21.02M | -128M |
EBT | 89.39M | 67.56M | 61.98M | 78.45M | 251M |
Gross Profit | 161M | 201M | 180M | 250M | 362M |
D&A | 25.86M | 25.48M | 29.3M | 29.5M | 28.47M |
Net Income | 80.28M | 53.98M | 48.9M | 59.17M | 217M |
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
United States of America | 99.55M | 132M | 115M | 243M | 331M |
| - | - | - | - | 37.55M | |
Europe | 42.72M | 45.02M | 62.59M | 48.62M | 86.14M |
| - | - | - | - | 36.62M | |
Mainland China | 85M | 101M | 74.12M | 94.58M | 78.97M |
Total Assets | 379M | 403M | 425M | 419M | 484M |
| - | - | - | - | 86.14M | |
Japan | 22.06M | 55.16M | 73.57M | 31.19M | 37.55M |
| - | - | - | - | 78.97M | |
Others | 32.8M | 16.93M | 11.69M | 24.64M | 36.62M |
Total Assets | 5.22M | 48.29M | 57.04M | 58.33M | 92.67M |
| - | - | - | - | 331M |
- Stock Market
- Stocks
- 3880 Stock
- Financials Medtide Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
